Clinical Trials on HCC - 肝细胞癌 in Hong Kong
总计645个结果
-
Humanity & Health Medical Group Limited招聘中
-
Humanity & Health Medical Group LimitedBeijing 302 Hospital; Kindai University Faculty of Medicine终止
-
Aegera TherapeuticsChinese University of Hong Kong完全的
-
Chinese University of Hong KongHealth and Medicine Research Fund招聘中
-
Chinese University of Hong KongThe Hong Kong Society of Gastroenterology完全的
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong Kong完全的
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong完全的
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong Kong完全的
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong Kong完全的
-
Chinese University of Hong KongPrince of Wales Hospital, Shatin, Hong Kong完全的
-
The University of Hong Kong未知
-
The University of Hong KongMerck KGaA, Darmstadt, Germany完全的
-
Chinese University of Hong Kong尚未招聘
-
Chinese University of Hong Kong主动,不招人EUS 引导氰基丙烯酸酯注射 | 内窥镜静脉曲张带结扎术 | 肝细胞癌 | 食管静脉曲张出血香港
-
Chinese University of Hong KongPrince of Wales Hospital, Shatin, Hong Kong终止
-
Bristol-Myers Squibb完全的
-
Astellas Pharma Inc终止
-
Novartis Pharmaceuticals完全的肝细胞癌 (HCC) | 实体恶性肿瘤美国, 德国, 台湾, 西班牙, 新加坡, 法国, 日本, 大韩民国, 香港, 中国, 意大利
-
The University of Hong KongEducation University of Hong Kong招聘中
-
Hospital Authority, Hong KongSchering-Plough未知
-
Blueprint Medicines Corporation完全的肝细胞癌 (HCC)中国, 大韩民国, 台湾, 香港, 英国, 美国, 法国, 西班牙, 瑞士, 新加坡, 德国, 意大利